[Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c].

Source:http://linkedlifedata.com/resource/pubmed/id/2954005

Download in:

View as

General Info

PMID
2954005